Revvity

Traded on the St. Petersburg Stock Exchange
Revvity is a global corporation focused in the business areas of diagnostics, life science research, food, environmental and industrial testing.
Revvity stock price chart
vol.
change
P/E
Net profit
P/B
Book value
Debts
Net debt
Yield
Growth potential

Revvity balance sheet

Report period2018 2019 2020 2021 2022Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Revvity cash flows

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Revvity multipliers

Report period2018 2019 2020 2021 2022Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Revvity profitability

Report period2017 2018 2019 2020 2021 2022
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Revvity assets
Revvity cash flows
Revvity dividends
0.27%

Revvity dividend policy

The company pays dividends on a quarterly basis.

Revvity shares

TickerNameTypeNominal valueISINPrice
RVTY:USRevvityCommon share-US7140461093$109.5
Revvity news
10.05.2023
PerkinElmer changed its name to Revvity. On May 16, the company will begin trading under the new ticker RVTY.
Source: {source} pictogram ir.revvity.com
Pictogram next
04.05.2022
Net income of PerkinElmer under GAAP for the 3 months of 2022 was $176.962 million, down 2.3 times from $379.305 million in the previous year. Revenue declined 3.7% to $1.259 billion from $1.308 billion a year earlier.
Source: ir.perkinelmer.com
Pictogram next
29.04.2022
The PerkinElmer Board of Directors announced a quarterly dividend of $0.07 per share. The last day to buy securities to receive the dividend is July 20, 2022. The annual dividend yield may reach 0.12%.
Source: ir.perkinelmer.com
Pictogram next
02.02.2022
PerkinElmer's GAAP net income for 2021 was $932.157 million, up 28.1% from $727.887 million in the prior year. Revenue increased 33.9% to $5.067 billion from $3.783 billion a year earlier.
Source: ir.perkinelmer.com
Pictogram next
All Revvity news
General information
Company nameRevvity
Tags#s&p500 index
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Life Sciences Tools & Services / Life Sciences Tools & Services
Business address940 WINTER STREET WALTHAM MA 02451 781 663 5776
Mailing address940 WINTER STREET WALTHAM MA 02451
Websiteir.revvity.com
Information disclosurewww.sec.gov